Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
6
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 6 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Clonidine Clonidine | D | $60.5M | -20% | 105,840 | $572 | $18.68 |
| Clonidine HCl Clonidine HCl | D | $22.5M | -35% | 912,575 | $25 | $0.06 |
| Clonidine HCl ER Clonidine HCl | D | $1.4M | -23% | 3,794 | $356 | $1.14 |
| Apraclonidine HCl Apraclonidine HCl | D | $337K | +5% | 1,857 | $181 | $10.17 |
| Clonidine HCL* Clonidine HCL/PF* · J0735 | B | $105K | -28% | 984 | $107 | $16.58 |
| Iopidine Apraclonidine HCl | D | $37K | n/a | 31 | $1,205 | $26.80 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.